Europe Direct-to-Consumer Laboratory Testing Market Insights, 2021-2031

Direct-to-Consumer Laboratory Testing Market (Test Type: Genetic Testing, Disease Risk Assessment Testing, CBC, Chronic Disease Testing, COVID-19 Testing, TSH Testing, and Others; Sample Type: Blood, Saliva, Urine, and Others; and Provider: Hospitals, Clinics, Specialty Labs, and Diagnostic Centers) - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Adoption of Direct-to-Consumer Laboratory Testing amid Covid-19 Pandemic

The Europe direct-to-consumer laboratory testing market witnessed an increasing demand due to consumer awareness in European countries. The increasing prevalence of infectious diseases post-pandemic is also driving the growth of the Europe direct-to-consumer laboratory testing market. Advancements in healthcare and adoption of direct-to-consumer laboratory testing methods are due to the rapidly spreading coronavirus in the European countries. Companies in the Europe direct-to-consumer laboratory testing market are focused on providing their services to cater to the increasing demand for consumer-driven laboratory testing procedures. These companies are striving to grab lucrative revenue opportunities by conducting rapid testing outside clinics and hospitals. Market players are entering into mergers & agreements with contract manufacturers to develop necessary testing kits that can be directly used by consumers.

europe direct to consumer laboratory testing market infographic

Request a sample to get extensive insights into the Direct-to-Consumer Laboratory Testing Market

Popularity Due to Increasing Consumer Awareness in European Countries

The Europe direct-to-consumer laboratory testing market is expected to surpass US$ 7.8 Bn by 2031. In countries such as Spain, Germany, France, and Italy, consumers are more aware of the advantages of direct-to-consumer laboratory tests over conventional laboratory testing methods. Increasing demand for disease risk assessment tests, COVID-19 tests, pregnancy tests, and various other nutrigenetics tests are boosting the Europe direct-to-consumer laboratory testing market. Governments are investing in promoting awareness and importance of such testing methods to cater to the increasing demand from consumers. The rising presence of companies and market players to provide these convenience services also fuels the Europe direct-to-consumer laboratory testing market.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Increasing Geriatric Population and Growing Prevalence of Infectious Diseases

With changing lifestyles and increasing prevalence of infectious diseases such as coronavirus, HIV, Influenza, etc., there is a continuous demand for rapid diagnosis and treatment. The rise in the number of lifestyle diseases such as diabetes, heart diseases, obesity, hypertension, cancer, etc. has augmented the demand for convenient diagnostic tests. Rapid test procedures, availability of test kits, and accurate results can prevent the spreading of such diseases. People are adopting innovative healthcare practices with rapid advancements in technologies. The increasing geriatric population in Europe is responsible for the increasing demand for convenient direct-to-consumer laboratory tests (DTC), which, in turn, boost the Europe direct-to-consumer laboratory testing market growth. Ongoing research & development in the direct-to-consumer procedures to perform variety of tests is likely to drive market in Europe.

Rapid Advancements in Healthcare, Test Confidentiality, and Convenience

Due to rapid advancements in the healthcare industry, acceptance of telehealth practices, and digitalization, people are becoming smarter to take advantage of recent trends and technologies that are being used in healthcare. Direct-to-consumer laboratory tests allow consumers to save their time and efforts to visit medical professionals for disease diagnosis. Direct-to-consumer laboratory tests can be ordered online from laboratory and test results are used to monitor health condition and to find out unknown medical disorders. This is the efficient way to involve consumer in the clinical diagnosis process; hence, they are called consumer-focused. The increasing popularity of such tests is due to its confidentiality and convenience where consumer need not have to wait for test results and tiring procedure to meet healthcare professionals. This factor contributes to the growth of the Europe direct-to-consumer laboratory testing market.

europe direct to consumer laboratory testing market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Direct-to-Consumer Laboratory Testing Market

Analysts’ Viewpoint

Increased awareness and genetic research & development activities initiated by various countries are driving the market in the region. The acceptance of modern technological practices introduced in the healthcare industry for the betterment of patients is also contributing to the Europe direct-to-consumer laboratory testing market growth. Consumer-driven testing is widely popular in European countries, due to its increased awareness, convenience, and accurate diagnosis of various health conditions. Increasing efforts of companies operating in the Europe direct-to-consumer laboratory testing market boost the demand for personalized healthcare services on a timely basis, where consumers can order test kits online and laboratory professionals delivers test results directly to the consumers without the involvement of health practitioners.

Europe Direct-to-Consumer Laboratory Testing Market: Overview

  • This report analyzes the current scenario and future prospects of the direct-to-consumer laboratory testing market in Europe. Direct-to-consumer laboratory testing, also known as direct access testing, allows patients to order tests directly from a lab without having to go through a healthcare professional. These test results can be used to track current health condition, diagnose a previously undiagnosed medical condition, or provide information on personal health traits. In line with the rise in demand for quick, affordable, and accurate tests, several companies have considered offering actionable recommendations to complement the test results. This approach induces customers to seek personalized services and maximizes customer satisfaction.
  • The report includes an elaborate executive summary, which provides a snapshot of various segments and sub-segments of the direct-to-consumer laboratory testing market in Europe. It also provides information and data analysis of the direct-to-consumer laboratory testing market in Europe about segments based on test type, sample type, provider, and country.
  • The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that affect the direct-to-consumer laboratory testing market in Europe
  • The report includes company profiles, which provide information about their business, product portfolios, strategic overview, and competitive landscape in the direct-to-consumer laboratory testing market in Europe
  • The report on the direct-to-consumer laboratory testing market in Europe offers market attractiveness analysis of regions and segments
  • The last section of the report comprises quantitative and qualitative analyses on market share/position of key players operating in the direct-to-consumer laboratory testing market in Europe. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the direct-to-consumer laboratory testing market in Europe.

Europe Direct-to-Consumer Laboratory Testing Market: Key Segments

  • In terms of test type, the direct-to-consumer laboratory testing market in Europe has been classified into genetic testing, disease risk assessment testing, CBC, chronic disease testing, COVID-19 testing, TSH testing, and others. The genetic testing segment has been split into nutrigenetics test, celiac disease test, sports & physical activity testing, men's health tests, women's health tests, pregnancy & prenatal screening, general health testing, and others. The nutrigenetics test sub-segment has been segregated into weight control, lactose intolerance, and others. The disease risk assessment testing segment has been categorized into sexual health tests, cancer predisposition tests, and others. The sexual health tests sub-segment has been split into HIV, chlamydia, and others. The chronic disease testing segment has been segregated into diabetes testing, hypertension, and others.
  • Based on sample type, the direct-to-consumer laboratory testing market in Europe has been categorized into blood, saliva, urine, and others
  • In terms of provider, the direct-to-consumer laboratory testing market in Europe has been divided into hospitals, clinics, specialty labs, and diagnostic centers
  • Market size and forecast for each of these segments and sub-segments have been provided from 2017 to 2031. The CAGR of respective segment has also been provided from 2021 to 2031, considering 2020 as the base year, and 2017, 2018, and 2019 as historical years.

Europe Direct-to-Consumer Laboratory Testing Market: Regional Outlook

  • In terms of country, the direct-to-consumer laboratory testing market in Europe has been segmented into the U.K., Germany, Spain, Italy, France, and Rest of Europe
  • The direct-to-consumer laboratory testing market report provides size and forecast for each country/sub-region from 2017 to 2031. The CAGR for each of these countries/sub-region has also been provided for the forecast period from 2021 to 2031. The direct-to-consumer laboratory testing market study covers the competitive scenario in these regions.

Companies Covered in Europe Direct-to-Consumer Laboratory Testing Market Report

  • Key players in the direct-to-consumer laboratory testing market in Europe have been profiled based on attributes such as company overview, product portfolio, financial overview, strategic overview, recent developments, and competitive business strategies
  • Major companies profiled in the direct-to-consumer laboratory testing market report are
    • 23andMe, Inc.
    • Ancestry
    • CircleDNA
    • Eurofins Scientific
    • Family Tree DNA (Gene by Gene)
    • Laboratory Corporation of America Holdings
    • Living DNA Ltd.
    • Medichecks.com Ltd.
    • MyHeritage Ltd.
    • MyMedLab, Inc.
    • Quest Diagnostics Incorporated

Europe Direct-to-Consumer Laboratory Testing Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 603 Mn

Market Forecast Value in 2031

US$ 7.8 Bn

Growth Rate (CAGR)

26%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes segment analysis at Europe as well as country level. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key industry events, etc.

Competition Landscape

Market share analysis by company (2020)

Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, key financials, etc.

Format

Electronic (PDF) + Excel

Market Segmentation

  • Test Type
  • Genetic Testing
    • Nutrigenetics Test
      • Weight Control
      • Lactose Intolerance
      • Others
    • Celiac Disease Test
    • Sports and Physical Activity Testing
    • Men's Health Tests
    • Women's Health Tests
    • Pregnancy and Prenatal Screening
    • General Health Testing
    • Others
  • Disease Risk Assessment Testing
    • Sexual Health Tests
      • HIV
      • Chlamydia
      • Others
    • Cancer Predisposition Tests
    • Others
  • CBC
  • Chronic Disease Testing
    • Diabetes Testing
    • Hypertension
    • Others
  • COVID-19 Testing
  • TSH Testing
  • Others
  • Sample Type
  • Blood
  • Saliva
  • Urine
  • Others
  • Provider
  • Hospitals
  • Clinics
  • Specialty Labs
  • Diagnostic Centers

Regions Covered

Europe

 

Germany

U.K.

France

Italy

Spain

Rest of Europe

Companies Profiled

23andMe, Inc.

Ancestry

CircleDNA

Eurofins Scientific

Family Tree DNA (Gene by Gene)

Laboratory Corporation of America Holdings

Living DNA Ltd.

Medichecks.com Ltd.

MyHeritage Ltd.

MyMedLab, Inc.

Quest Diagnostics Incorporated

Customization Scope

Available upon request

Pricing

Available upon request

Europe Direct-to-Consumer Laboratory Testing Market – Segmentation

Test Type
  • Genetic Testing
    • Nutrigenetics Test
      • Weight Control
      • Lactose Intolerance
      • Others
    • Celiac Disease Test
    • Sports & Physical Activity Testing
    • Men's Health Tests
    • Women's Health Tests
    • Pregnancy & Prenatal Screening
    • General Health Testing
    • Others
  • Disease Risk Assessment Testing
    • Sexual Health Tests
      • HIV
      • Chlamydia
      • Others
    • Cancer Predisposition Tests
    • Others
  • CBC
  • Chronic Disease Testing
    • Diabetes Testing
    • Hypertension
    • Others
  • COVID-19 Testing
  • TSH Testing
  • Others
Sample Type
  • Blood
  • Saliva
  • Urine
  • Others
Provider
  • Hospitals
  • Clinics
  • Specialty Labs
  • Diagnostic Centers
Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe

Frequently Asked Questions

What is the total market worth of europe direct-to-consumer laboratory testing market?

Europe direct-to-consumer laboratory testing market is expected to surpass US$ 7.8 Bn by 2031

What is the anticipated CAGR of the europe direct-to-consumer laboratory testing market in the forecast period?

Europe direct-to-consumer laboratory testing market is driven by increasing geriatric population and growing prevalence of infectious diseases

What are the key driving factors for the growth of the europe direct-to-consumer laboratory testing market?

Europe direct-to-consumer laboratory testing market is driven by increasing geriatric population and growing prevalence of infectious diseases

Which is the rising prominent segment in the europe direct-to-consumer laboratory testing market?

The diagnostic centers segment dominated the direct-to-consumer laboratory testing market in Europe during the forecast period.

Who are the key players in the europe direct-to-consumer laboratory testing market?

Key players in the direct-to-consumer laboratory testing market include 23andMe, Inc., Ancestry, CircleDNA, Eurofins Scientific, Family Tree DNA (Gene by Gene)

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Europe Direct-to-Consumer Laboratory Testing Market

    4. Market Overview

        4.1. Introduction

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Key Industrial Events (licensing partnerships/mergers & acquisitions)

        5.2. Disease Prevalence & Incidence Rate

        5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    6. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Sample Type, 2017–2031

            6.3.1. Blood

            6.3.2. Urine

            6.3.3. Saliva

            6.3.4. Others

        6.4. Market Attractiveness Analysis, by Sample Type

    7. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Test Type, 2017–2031

            7.3.1. Genetic Testing

                7.3.1.1. Nutrigenetics Test

                    7.3.1.1.1. Weight Control

                    7.3.1.1.2. Lactose Intolerance

                    7.3.1.1.3. Others

                7.3.1.2. Celiac Disease Test

                7.3.1.3. Sports & Physical Activity Testing

                7.3.1.4. Men's Health Tests

                7.3.1.5. Women's Health Tests

                7.3.1.6. Pregnancy & Prenatal Screening Test

                7.3.1.7. General Health Testing

                7.3.1.8. Others

            7.3.2. Disease Risk Assessment Testing

                7.3.2.1. Sexual Health Tests

                    7.3.2.1.1. HIV

                    7.3.2.1.2. Chlamydia

                    7.3.2.1.3. Others

                7.3.2.2. Cancer Predisposition Tests

                7.3.2.3. Others

            7.3.3. CBC

            7.3.4. Chronic Disease Testing

                7.3.4.1. Diabetes Testing

                7.3.4.2. Hypertension

                7.3.4.3. Others

            7.3.5. COVID-19 Testing

            7.3.6. TSH Testing

            7.3.7. Others

        7.4. Market Attractiveness Analysis, by Test Type

    8. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Provider

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by Provider, 2017–2031

            8.3.1. Hospitals

            8.3.2. Clinics

            8.3.3. Speciality Labs

            8.3.4. Diagnostic Centres

        8.4. Market Attractiveness Analysis, by Provider

    9. Germany Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Market Value Forecast, by Sample Type, 2017–2031

            9.2.1. Blood

            9.2.2. Urine

            9.2.3. Saliva

            9.2.4. Others

        9.3. Market Value Forecast, by Test Type, 2017–2031

            9.3.1. Genetic Testing

                9.3.1.1. Nutrigenetics Test

                    9.3.1.1.1. Weight Control

                    9.3.1.1.2. Lactose Intolerance

                    9.3.1.1.3. Others

                9.3.1.2. Celiac Disease Test

                9.3.1.3. Sports & Physical Activity Testing

                9.3.1.4. Men's Health Tests

                9.3.1.5. Women's Health Tests

                9.3.1.6. Pregnancy & Prenatal Screening Test

                9.3.1.7. General Health Testing

                9.3.1.8. Others

            9.3.2. Disease Risk Assessment Testing

                9.3.2.1. Sexual Health Tests

                    9.3.2.1.1. HIV

                    9.3.2.1.2. Chlamydia

                    9.3.2.1.3. Others

                9.3.2.2. Cancer Predisposition Tests

                9.3.2.3. Others

            9.3.3. CBC

            9.3.4. Chronic Disease Testing

                9.3.4.1. Diabetes Testing

                9.3.4.2. Hypertension

                9.3.4.3. Others

            9.3.5. COVID-19 Testing

            9.3.6. TSH Testing

            9.3.7. Others

        9.4. Market Value Forecast, by Provider, 2017–2031

            9.4.1. Hospitals

            9.4.2. Clinics

            9.4.3. Speciality Labs

            9.4.4. Diagnostic Centres

    10. U.K. Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Sample Type, 2017–2031

            10.2.1. Blood

            10.2.2. Urine

            10.2.3. Saliva

            10.2.4. Others

        10.3. Market Value Forecast, by Test Type, 2017–2031

            10.3.1. Genetic Testing

                10.3.1.1. Nutrigenetics Test

                    10.3.1.1.1. Weight Control

                    10.3.1.1.2. Lactose Intolerance

                    10.3.1.1.3. Others

                10.3.1.2. Celiac Disease Test

                10.3.1.3. Sports & Physical Activity Testing

                10.3.1.4. Men's Health Tests

                10.3.1.5. Women's Health Tests

                10.3.1.6. Pregnancy & Prenatal Screening Test

                10.3.1.7. General Health Testing

                10.3.1.8. Others

            10.3.2. Disease Risk Assessment Testing

                10.3.2.1. Sexual Health Tests

                    10.3.2.1.1. HIV

                    10.3.2.1.2. Chlamydia

                    10.3.2.1.3. Others

                10.3.2.2. Cancer Predisposition Tests

                10.3.2.3. Others

                10.3.2.4. CBC

                10.3.2.5. Chronic Disease Testing

                    10.3.2.5.1. Diabetes Testing

                    10.3.2.5.2. Hypertension

                    10.3.2.5.3. Others

                10.3.2.6. COVID-110 Testing

                10.3.2.7. TSH Testing

                10.3.2.8. Others

        10.4. Market Value Forecast, by Provider, 2017–2031

            10.4.1. Hospitals

            10.4.2. Clinics

            10.4.3. Speciality Labs

            10.4.4. Diagnostic Centres

    11. France Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Sample Type, 2017–2031

            11.2.1. Blood

            11.2.2. Urine

            11.2.3. Saliva

            11.2.4. Others

        11.3. Market Value Forecast, by Test Type, 2017–2031

            11.3.1. Genetic Testing

                11.3.1.1. Nutrigenetics Test

                    11.3.1.1.1. Weight Control

                    11.3.1.1.2. Lactose Intolerance

                    11.3.1.1.3. Others

                11.3.1.2. Celiac Disease Test

                11.3.1.3. Sports & Physical Activity Testing

                11.3.1.4. Men's Health Tests

                11.3.1.5. Women's Health Tests

                11.3.1.6. Pregnancy & Prenatal Screening Test

                11.3.1.7. General Health Testing

                11.3.1.8. Others

            11.3.2. Disease Risk Assessment Testing

                11.3.2.1. Sexual Health Tests

                    11.3.2.1.1. HIV

                    11.3.2.1.2. Chlamydia

                    11.3.2.1.3. Others

                11.3.2.2. Cancer Predisposition Tests

                11.3.2.3. Others

            11.3.3. CBC

            11.3.4. Chronic Disease Testing

                11.3.4.1. Diabetes Testing

                11.3.4.2. Hypertension

                11.3.4.3. Others

            11.3.5. COVID-19 Testing

            11.3.6. TSH Testing

            11.3.7. Others

        11.4. Market Value Forecast, by Provider, 2017–2031

            11.4.1. Hospitals

            11.4.2. Clinics

            11.4.3. Speciality Labs

            11.4.4. Diagnostic Centres

    12. Italy Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Sample Type, 2017–2031

            12.2.1. Blood

            12.2.2. Urine

            12.2.3. Saliva

            12.2.4. Others

        12.3. Market Value Forecast, by Test Type, 2017–2031

            12.3.1. Genetic Testing

                12.3.1.1. Nutrigenetics Test

                    12.3.1.1.1. Weight Control

                    12.3.1.1.2. Lactose Intolerance

                    12.3.1.1.3. Others

                12.3.1.2. Celiac Disease Test

                12.3.1.3. Sports & Physical Activity Testing

                12.3.1.4. Men's Health Tests

                12.3.1.5. Women's Health Tests

                12.3.1.6. Pregnancy & Prenatal Screening Test

                12.3.1.7. General Health Testing

                12.3.1.8. Others

            12.3.2. Disease Risk Assessment Testing

                12.3.2.1. Sexual Health Tests

                    12.3.2.1.1. HIV

                    12.3.2.1.2. Chlamydia

                    12.3.2.1.3. Others

                12.3.2.2. Cancer Predisposition Tests

                12.3.2.3. Others

            12.3.3. CBC

            12.3.4. Chronic Disease Testing

                12.3.4.1. Diabetes Testing

                12.3.4.2. Hypertension

                12.3.4.3. Others

            12.3.5. COVID-19 Testing

            12.3.6. TSH Testing

            12.3.7. Others

        12.4. Market Value Forecast, by Provider, 2017–2031

            12.4.1. Hospitals

            12.4.2. Clinics

            12.4.3. Speciality Labs

            12.4.4. Diagnostic Centres

    13. Spain Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Sample Type, 2017–2031

            13.2.1. Blood

            13.2.2. Urine

            13.2.3. Saliva

            13.2.4. Others

        13.3. Market Value Forecast, by Test Type, 2017–2031

            13.3.1. Genetic Testing

                13.3.1.1. Nutrigenetics Test

                    13.3.1.1.1. Weight Control

                    13.3.1.1.2. Lactose Intolerance

                    13.3.1.1.3. Others

                13.3.1.2. Celiac Disease Test

                13.3.1.3. Sports & Physical Activity Testing

                13.3.1.4. Men's Health Tests

                13.3.1.5. Women's Health Tests

                13.3.1.6. Pregnancy & Prenatal Screening Test

                13.3.1.7. General Health Testing

                13.3.1.8. Others

            13.3.2. Disease Risk Assessment Testing

                13.3.2.1. Sexual Health Tests

                    13.3.2.1.1. HIV

                    13.3.2.1.2. Chlamydia

                    13.3.2.1.3. Others

                13.3.2.2. Cancer Predisposition Tests

                13.3.2.3. Others

            13.3.3. CBC

            13.3.4. Chronic Disease Testing

                13.3.4.1. Diabetes Testing

                13.3.4.2. Hypertension

                13.3.4.3. Others

            13.3.5. COVID-19 Testing

            13.3.6. TSH Testing

            13.3.7. Others

        13.4. Market Value Forecast, by Provider, 2017–2031

            13.4.1. Hospitals

            13.4.2. Clinics

            13.4.3. Speciality Labs

            13.4.4. Diagnostic Centres

    14. Rest of Europe Countries Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Sample Type, 2017–2031

            14.2.1. Blood

            14.2.2. Urine

            14.2.3. Saliva

            14.2.4. Others

        14.3. Market Value Forecast, by Test Type, 2017–2031

            14.3.1. Genetic Testing

                14.3.1.1. Nutrigenetics Test

                    14.3.1.1.1. Weight Control

                    14.3.1.1.2. Lactose Intolerance

                    14.3.1.1.3. Others

                14.3.1.2. Celiac Disease Test

                14.3.1.3. Sports & Physical Activity Testing

                14.3.1.4. Men's Health Tests

                14.3.1.5. Women's Health Tests

                14.3.1.6. Pregnancy & Prenatal Screening Test

                14.3.1.7. General Health Testing

                14.3.1.8. Others

            14.3.2. Disease Risk Assessment Testing

                14.3.2.1. Sexual Health Tests

                    14.3.2.1.1. HIV

                    14.3.2.1.2. Chlamydia

                    14.3.2.1.3. Others

                14.3.2.2. Cancer Predisposition Tests

                14.3.2.3. Others

            14.3.3. CBC

            14.3.4. Chronic Disease Testing

                14.3.4.1. Diabetes Testing

                14.3.4.2. Hypertension

                14.3.4.3. Others

            14.3.5. COVID-19 Testing

            14.3.6. TSH Testing

            14.3.7. Others

        14.4. Market Value Forecast, by Provider, 2017–2031

            14.4.1. Hospitals

            14.4.2. Clinics

            14.4.3. Speciality Labs

            14.4.4. Diagnostic Centres

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (by tier and size of companies)

        15.2. Company Profiles

            15.2.1. 23andMe, Inc.

                15.2.1.1. Company Description

                15.2.1.2. Business Overview

                15.2.1.3. Strategic Overview

                15.2.1.4. SWOT Analysis

            15.2.2. Ancestry

                15.2.2.1. Company Description

                15.2.2.2. Business Overview

                15.2.2.3. SWOT Analysis

            15.2.3. CircleDNA

                15.2.3.1. Company Description

                15.2.3.2. Business Overview

                15.2.3.3. SWOT Analysis

            15.2.4. Eurofins Scientific

                15.2.4.1. Company Description

                15.2.4.2. Business Overview

                15.2.4.3. Financial Overview

                15.2.4.4. SWOT Analysis

            15.2.5. Family Tree DNA (Gene by Gene)

                15.2.5.1. Company Description

                15.2.5.2. Business Overview

                15.2.5.3. SWOT Analysis

            15.2.6. Laboratory Corporation of America Holdings

                15.2.6.1. Company Description

                15.2.6.2. Business Overview

                15.2.6.3. Financial Overview

                15.2.6.4. Strategic Overview

                15.2.6.5. SWOT Analysis

            15.2.7. Living DNA Ltd.

                15.2.7.1. Company Description

                15.2.7.2. Business Overview

                15.2.7.3. SWOT Analysis

            15.2.8. Medichecks.com Ltd.

                15.2.8.1. Company Description

                15.2.8.2. Business Overview

                15.2.8.3. SWOT Analysis

            15.2.9. MyHeritage Ltd.

                15.2.9.1. Company Description

                15.2.9.2. Business Overview

                15.2.9.3. SWOT Analysis

            15.2.10. MyMedLab, Inc.

                15.2.10.1. Company Description

                15.2.10.2. Business Overview

                15.2.10.3. SWOT Analysis

            15.2.11. Quest Diagnostics Incorporated

                15.2.11.1. Company Description

                15.2.11.2. Business Overview

                15.2.11.3. Financial Overview

                15.2.11.4. Strategic Overview

                15.2.11.5. SWOT Analysis

    List of Tables

    Table 01: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

    Table 02: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 03: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

    Table 04: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

    Table 05: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

    Table 06: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

    Table 07: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

    Table 08: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

    Table 09: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

    Table 10: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 11: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

    Table 12: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

    Table 13: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

    Table 14: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

    Table 15: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

    Table 16: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

    Table 17: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

    Table 18: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 19: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

    Table 20: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

    Table 21: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

    Table 22: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

    Table 23: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

    Table 24: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

    Table 25: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

    Table 26: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 27: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

    Table 28: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

    Table 29: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

    Table 30: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

    Table 31: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

    Table 32: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

    Table 33: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

    Table 34: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 35: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

    Table 36: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

    Table 37: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

    Table 38: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

    Table 39: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

    Table 40: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

    Table 41: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

    Table 42: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 43: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

    Table 44: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

    Table 45: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

    Table 46: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

    Table 47: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

    Table 48: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

    Table 49: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

    Table 50: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 51: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

    Table 52: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

    Table 53: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

    Table 54: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

    Table 55: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

    Table 56: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

    List of Figures

    Figure 01: Europe Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

    Figure 02: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

    Figure 03: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Blood, 2017–2031

    Figure 04: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031

    Figure 05: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031

    Figure 06: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

    Figure 07: Europe Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

    Figure 08: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

    Figure 09: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Genetic Testing, 2017–2031

    Figure 10: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Disease Risk Assessment Testing, 2017–2031

    Figure 11: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by CBC, 2017–2031

    Figure 12: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Chronic Disease Testing, 2017–2031

    Figure 13: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by COVID-19 Testing, 2017–2031

    Figure 14: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by TSH Testing, 2017–2031

    Figure 15: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

    Figure 16: Europe Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

    Figure 17: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

    Figure 18: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Hospitals, 2017–2031

    Figure 19: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Clinics, 2017–2031

    Figure 20: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Specialty Labs, 2017–2031

    Figure 21: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Diagnostic Centers, 2017–2031

    Figure 22: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

    Figure 23: Germany Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

    Figure 24: Germany Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

    Figure 25: Germany Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

    Figure 26: Germany Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

    Figure 27: Germany Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

    Figure 28: Germany Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

    Figure 29: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

    Figure 30: U.K. Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

    Figure 31: U.K. Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

    Figure 32: U.K. Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

    Figure 33: U.K. Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

    Figure 34: U.K. Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

    Figure 35: U.K. Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

    Figure 36: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

    Figure 37: France Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

    Figure 38: France Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

    Figure 39: France Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

    Figure 40: France Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

    Figure 41: France Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

    Figure 42: France Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

    Figure 43: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

    Figure 44: Italy Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

    Figure 45: Italy Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

    Figure 46: Italy Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

    Figure 47: Italy Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

    Figure 48: Italy Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

    Figure 49: Italy Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

    Figure 50: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

    Figure 51: Spain Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

    Figure 52: Spain Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

    Figure 53: Spain Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

    Figure 54: Spain Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

    Figure 55: Spain Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

    Figure 56: Spain Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Copyright © Transparency Market Research, Inc. All Rights reserved